the anamnestic response after administration of a booster dose, infection rate in vaccinated populations, in vitro B and T cell activity testing, and seroepidemiological studies.
Long-
term protection is present despite a decrease
in anti-hepatitis B surface antibodies over time. The exact mechanism of long-term protection, however, is not yet fully understood.